| Literature DB >> 35784521 |
Hamed Vahedi1, Carter M Taft2, Joshua R Daum1, Sherif Dabash1, Patrick C McCulloch1, Bradley S Lambert1.
Abstract
We recently observed a high prevalence of low pelvic bone mineral density (BMD) in female professional ballet performers. Because this population is susceptible to musculoskeletal overuse injuries, we aimed to determine which regions of the pelvis may be at greatest risk compared to general population females (GENPOP) as well as professional female soccer players (SOCCER, a comparison to other elite athletes regularly subjected to high degrees of loading). Three groups of age-matched females [(GENPOP; n = 38, 27±1yrs), (BALLET; single company, n = 36, 26±3yrs), (SOCCER; single NWSL® club, n = 34, 25±1yrs)] consented to have their BMD and body composition assessed (DEXA, GE®). In addition to soft tissue and total and regional BMD analyses, a segmental analysis of the pelvis was performed to determine site-specific BMD for the iliac fossa, iliac fossa/iliac crest/ilium combined, pubic bone, ischium, and sacrum. A mixed-model ANOVA followed by a Tukey's post-hoc test was used to compare the groups (Type-I error; α = 0.05). The BALLET group had lower pelvic BMD for all measures (Avg.%Diff. = 15%-27%, p<0.001) compared to the SOCCER group and for the ischium (Avg.%Diff.= 8%; p=0.007) and sacrum (Avg.%Diff. = 7%; p = 0.028) compared to the GENPOP group. The BALLET group had lower lean mass for all measures compared to the other groups (Avg.%Diff. = 12%-18%; p < 0.01). Professional ballet performers exhibit reduced pelvic region soft tissue and site-specific BMD not previously detected using standard DEXA analyses. These findings highlight which pelvic regions may benefit from preventative strength training and/or nutritional interventions.Entities:
Keywords: 95%CI, 95% Confidence Interval; Athlete; BALLET, Professional Female Ballet Performers; BMD, Bone Mineral Density (g/cm2); Ballet; Bone; Bone density; DEXA, Dual-Energy X-Ray Absorptiometry; ES, Effect Size (Cohen's d for continuous data, Phi statistic for frequency comparisons); FMI, Fat Mass Index (Fat Mass, kg / height, m2); Female athlete; Fossa, Iliac Fossa; GENPOP, General Population Females; IC-F-I, iliac crest, iliac fossa, ischium, combined; ICC, Interclass Correlation Coefficient; LMI, Lean Mass Index (Lean Mass, kg / height, m2); SOCCER, Professional Female Soccer Athletes (Major League Soccer, MLS®)
Year: 2021 PMID: 35784521 PMCID: PMC9219303 DOI: 10.1016/j.smhs.2021.08.002
Source DB: PubMed Journal: Sports Med Health Sci ISSN: 2666-3376
Fig. 1Dual-hip and femur scan example (iDXA, GE®).
Fig. 2Regional Pelvic BMD. Data are presented as means95%CI for regional pelvic bone mineral density (BMD, g/cm2) analysis at the following sites: Iliac fossa (fossa); combined - Iliac crest, iliac fossa, and ilium (IC-F-I); Pubic bone; Ischium; Sacrum. Like letters = not significantly different between groups (p<0.05). p-values (Sig.) are provided below each figure for pairwise comparisons in addition to effect sizes (ES) reported as Cohen's d statistics for all significant comparisons interpreted as: < 0.1, negligible effect size (N); 0.1-0.3, small effect size (S); 0.5-0.7, large effect size (L); and > 0.7, very large effect size (VL).
Demographics.
| GEN POP ( | BALLET ( | SOCCER ( | GEN POP vs. BALLET | GEN POP vs. SOCCER | BALLET vs. SOCCER | |
|---|---|---|---|---|---|---|
| 27 ± 1 | 26 ± 3 | 25 ± 1 | ns | ns | ns | |
| 168.4 ± 2.8 | 164.7 ± 1.4 | 167.1 ± 1.9 | ns | |||
| 68.8 ± 4.2 | 51.5 ± 1.5 | 62.6 ± 1.9 | ||||
| 24.1 ± 1.0 | 19.0 ± 0.4 | 22.4 ± 0.5 | ||||
| 29.5 ± 2.0 | 20.6 ± 1.4 | 22.2 ± 1.3 | ns | |||
| 1.22 ± 0.03 | 1.15 ± 0.02 | 1.38 ± 0.03 | ||||
| 1.12 ± 0.04 | 1.03 ± 0.04 | 1.25 ± 0.04 | ||||
| 1.14 ± 0.04 | 1.05 ± 0.03 | 1.35 ± 0.04 | ||||
| 1.24 ± 0.04 | 1.19 ± 0.03 | 1.45 ± 0.03 | ns | |||
| Total ( | 26 | 1 | ||||
| Unique Athletes ( | 13 | 1 | ||||
| %Athletes in Group | 36% | 3% | ||||
| | 1 | 0 | ||||
| | 4 | 0 | ||||
| | 21 | 1 | ||||
| Total ( | 21 | 1 | ||||
| Unique Athletes ( | 12 | 1 | ||||
| %Athletes in Group | 33% | 3% | ||||
| | 0 | 0 | ||||
| | 2 | 0 | ||||
| | 19 | 1 | ||||
| Total ( | 5 | 0 | ||||
| Unique Athletes | 3 | 0 | ||||
| %Athletes in Group | 8% | 0% | ns | |||
| | 1 | 0 | ||||
| | 2 | 0 | ||||
| | 2 | 0 | ||||
| | Moderate to vigorous physical activity >30 min on 3 or more days/week for recreational fitness training | |||||
| | Contracted for performance or rehearsal: 6 h/day; 5-6 days/week; 43 weeks/year; ~1290-1548 h/year | |||||
| | Contracted for practice or performance: 2.5 h/day; 5-6 days/week; 30 weeks/year; ~375-450 h/year | |||||
Values are presented as means ± 95%CI for age (years), height (centimeters, cm), weight (kilograms, kg), body mass index (BMI, kg/m2), and %body fat (%fat) and bone mineral density (BMD, g/cm2; Total Body, Spine, Pelvis, Legs). Data are also presented for pelvic region injury frequencies (and counts by level of injury) for the BALLET and SOCCER groups (all injuries, soft tissue injuries, and bone injuries). Injury level defined as: Level 3 – Musculoskeletal Complaint with Full Participation (athlete sought medical treatment from a licensed physician but was fully able to participate in activities); Level 2 – Musculoskeletal Complaint with Modified Participation (anatomic tissue-level impairment as diagnosed by a licensed physician resulting in activity modification but no time loss); Level 1 – Injury (anatomic tissue-level impairment as diagnosed by a licensed physician that resulted in full time loss from activity for one or more days). Injury data are expressed as total, soft tissue (muscle, ligament, tendon) and bone injuries within the pelvic region. Injury data are also tabulated as the total number of injuries (total) as well as how many unique invidual athletes experienced at least one injury. Results of pairwise post-hoc comparisons are shown on the right. Type I Error set at α=0.05 for all comparisons. For significant pairwise comparisons, effect sizes (ES) are interpreted as follows: < 0.1, negligible (N); 0.1-0.3, small (S); 0.5-0.7, large (L); and > 0.7, very large (VL).
Fig. 3Regional Soft Tissue Distribution. Data are presented as means95%CI for regional (A) lean and (B) fat tissue distribution expressed as lean mass index (lean mass, kg/height, m2) and fat mass index (fat mass, kg/height, m2). Like letters = not significantly different between groups (p < 0.05). P-values (Sig.) are provided below each figure for pairwise comparisons in addition to effect sizes (ES) reported as Cohen's d statistics for all significant comparisons interpreted as: < 0.1, negligible effect size (N); 0.1-0.3, small effect size (S); 0.5-0.7, large effect size (L); and > 0.7, very large effect size (VL).